Cullinan Therapeutics, Inc. (CGEM)
15.03
-0.42
(-2.72%)
USD |
NASDAQ |
Oct 30, 16:00
14.90
-0.13
(-0.86%)
After-Hours: 20:00
Cullinan Therapeutics Free Cash Flow : -159.26M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -159.26M |
| March 31, 2026 | -178.65M |
| December 31, 2025 | -175.76M |
| September 30, 2025 | -174.27M |
| June 30, 2025 | -171.53M |
| March 31, 2025 | -150.21M |
| December 31, 2024 | -145.30M |
| September 30, 2024 | -126.81M |
| June 30, 2024 | -126.81M |
| March 31, 2024 | -121.57M |
| December 31, 2023 | -134.48M |
| September 30, 2023 | -142.22M |
| Date | Value |
|---|---|
| June 30, 2023 | -162.68M |
| March 31, 2023 | -157.04M |
| December 31, 2022 | -127.80M |
| September 30, 2022 | -117.10M |
| June 30, 2022 | -73.05M |
| March 31, 2022 | -63.83M |
| December 31, 2021 | -43.43M |
| September 30, 2021 | -37.70M |
| June 30, 2021 | -36.22M |
| March 31, 2021 | -26.28M |
| December 31, 2020 | -29.78M |
| September 30, 2020 | -25.22M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Climb Bio, Inc. | -53.07M |
| MapLight Therapeutics, Inc. | -175.12M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.22M |
| Cash from Investing (Quarterly) | 40.68M |
| Cash from Financing (Quarterly) | 1.10M |
| Free Cash Flow Per Share (Quarterly) | -0.6167 |
| Free Cash Flow to Equity (Quarterly) | -37.91M |
| Free Cash Flow to Firm (Quarterly) | -38.22M |
| Free Cash Flow Yield | -17.57% |